Malaria chemoprophylaxis during pregnancy: a survey of current practice amongst general practitioners in Port Harcourt, Nigeria
Main Article Content
Abstract
Background: Malaria is a common health problem especially among the pregnant women in endemic countries such as Nigeria . Sulphadoxine/pyrimethamine (SP) has been recommended by the World Health Organisation (WHO) for malaria chemoprophylaxis in pregnancy and has been incorporated into our national malaria control programme. General medical practitioners provide prenatal care for significant proportion of our women in pregnancy.
Aim: To examine the current knowledge and practice of malaria chemoprophylaxis during pregnancy among general medical practitioners in Port Harcourt, southern Nigeria.
Methods: It was a questionnaire based study of 90 general medical practitioners in Port Harcourt, southern Nigeria which sought for their socio- demographic characteristics and knowledge and practice of malaria chemoprophylaxis during pregnancy. The data were entered into a personal computer and analysed using SPSS for windows version 10.0 and presented as frequency tables and percentages.
Results: Of the 90 questionnaires, 59 duly completed forms were retrieved, giving a response rate of 65.60%. The age range of the respondents was 21-60 years with 31-40 years as the most common range. Only 33(55.93%) respondents knew the current malaria chemoprophylactic agent in pregnancy as recommended by WHO. Almost all (98.30%) respondents administered malaria chemoprophylaxis routinely to their antenatal women but only 44.06% administered correctly SP as recommended.
Conclusion: The knowledge and practice of the WHO recommended malaria chemoprophylaxis in pregnancy among general medical practitioners is below average. Training and re-training of these primary care physicians on the use of sulphadoxine-pyrimethamine will tremendously improve their knowledge and practice of this WHO recommended chemoprophylactic agent in pregnancy which will in turn reduce malaria - related perinatal and maternal complications.
Downloads
Article Details
The journal grants the right to make small numbers of printed copies for their personal non-commercial use under Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported License.
References
1. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria endemic areas. Am J Trop Med Hyg 2001; 64(1-2Suppl): 28-35.
2. Agomo CO, Oyibo WA, Anorlu RI, Agomo PU. Prevalence of malaria in pregnant women in Lagos, South-West Nigeria. Korean J Parasitol 2009; 47: 179-183.
3. Opare-Addo HS, Odoi AT. Malaria in pregnancy. In: Kwawukume EY, Emuveyan EE, eds. Comprehensive obstetrics for the tropics. Dansoman: Asante and Hittscher Printing Press Ltd, 2002; 250-260.
4. Newman RD, Parise ME, Slutsker L, Nahlen BL, Steketee RW. Safety, efficacy and determinants of effectiveness of antimalarial drugs during pregnancy: implications for prevention programmes in plasmodium endemic areas in sub-Saharan Africa. Trop Med Int Health 2003; 8: 488-506.
5. Wagbatsoma VA, Omoike BI. Prevalence and prevention of malaria in pregnancy in Edo, State, Nigeria. Afr J Reprod Health 2008; 12: 49-
58.
6. Shulman CE, Dorman EK, Bulmer JN. Malaria as a cause of severe anaemia in pregnancy. Lancet 2002; 360(9331): 494.
7. Luxemburger C, McGready R, Kham A, Morson L, Chongsuphajaisiddhi T, White NJ,et al. Effects of malaria during pregnancy on infant mortality in areas of low malaria transmission. Am J Epidemiol 2001; 154: 459-465.
8. Sowunmi A. Malaria during pregnancy. In: Okonofua FE, Odunsi K, eds. Contemporary obstetrics and gynaecology for developing countries. Benin City: Women Health and Action Research Centre, 2003; 502-513.
9. Federal Ministry of Health. National antimalarial treatment policy. Abuja, Nigeria: Federal Ministry of Health, National Malaria and Vector control division,2005.
10. Wellems TE, Plowe CV. Chloroquine-resistant malaria. J Infect Dis 2001: 184: 70-76.
11. World Health Organisation regional office for Africa. Disease prevention and control: malaria-10 facts on malaria in Africa. Available at www.afro.whoint. Accessed September10, 2011.
12. Mbaye A, Richardson K, Balajo B, Dunyo S, Shulman C, Milligan P, Greenwood B, et al. A randomized, placebo-controlled trial of intermittent preventive treatment with sulphadoxine-pyremithamine in Gambian multigravidae. Trop Med Int Health 2006; 11: 992-
1002.
13. World Health Organisation. Role Back Malaria. Malaria in pregnancy. Available a t www.rbm.who.int/cmc. Accessed September 10, 2011.
14. Ugwu EO, Iferikigwe ES, Obi SN, Ugwu AO, Agu PU, Okezie OA. Antimalaria prescription in pregnancy among general practitioners in Enugu state, south-east Nigeria. Niger Med J 2013; 54: 96-99.
15. Onah HE, Nkwo PO, Nwankwo TO. Malaria chemoprophylaxis during pregnancy; a survey of current practice amongst Nigerian obstetricians. Trop J Obstet Gynaecol 2006; 23: 17-19.
16. FaladeCO, Yusuf BO, Fadero FF, Mokuolu OA, Hamer DH, Salako LA. Intermittent preventive treatment with sulphadoxine- pyremithamine is effective in preventing maternal and placental malaria in Ibadan, south-western Nigeria. Malar J 2007; 6: 88.
17. Sabin LL, Rizal A, Brookes MI, Singh MP, Tuchman J, Wylie BJ, Joyce KM, et al. Attitudes, knowledge and practices regarding malaria prevention and treatment among pregnant women in Eastern India. Am J Trop Med Hyg 2010; 82: 1010-1016.